Evidence map›Paper›PMID 35469031›Full record

ArticleEuropean journal of pediatrics2022

Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, China.

Tian Geng, Zhong-Su Yu, Xi-Xi Zhou, Bo Liu, Hui-Hua Zhang, Zhong-Yue Li

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Antibiotic resistance and associated gene mutations ofFrontiers in cellular and infection microbiology · 2026
    Article
  4. Global Profile of Drug Resistance Related toHealth science reports · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Antibiotics (Basel, Switzerland) · 2023
    Review
  9. Review
  10. Current Worldwide Trends in PediatricChildren (Basel, Switzerland) · 2023
    Review
  11. Comparison of multiple treatment regimens in children withFrontiers in cellular and infection microbiology · 2023
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Tian GengDepartment of Gastroenterology, National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, No. 136, 2nd Zhongshan Road, Yuzhong District, Chongqing, People's Republic of China.ORCID http://orcid.org/0000-0002-6298-3773
Zhong-Su YuDepartment of Gastroenterology, National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, No. 136, 2nd Zhongshan Road, Yuzhong District, Chongqing, People's Republic of China.
Xi-Xi ZhouDepartment of Gastroenterology, National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, No. 136, 2nd Zhongshan Road, Yuzhong District, Chongqing, People's Republic of China.
Bo LiuDepartment of Gastroenterology, National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, No. 136, 2nd Zhongshan Road, Yuzhong District, Chongqing, People's Republic of China.
Hui-Hua ZhangDepartment of Gastroenterology, National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, No. 136, 2nd Zhongshan Road, Yuzhong District, Chongqing, People's Republic of China.
Zhong-Yue LiDepartment of Gastroenterology, National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, No. 136, 2nd Zhongshan Road, Yuzhong District, Chongqing, People's Republic of China. lizhongyue1001@hotmail.com.ORCID http://orcid.org/0000-0002-2381-3528
China International Science and Technology Cooperation · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The resistance of Helicobacter pylori (H. pylori) to antibiotics has been increasing worldwide and varies across different geographic areas and times. Limited studies reported the prevalence of antibiotic resistance and its related gene mutations in children in Chongqing, a city located in southwest China. We collected 112 H. pylori strains isolated from gastric biopsies of 156 children at Children's Hospital of Chongqing Medical University and calculated resistance rates of these strains to six antibiotics. The A2143G and A2142G mutations in 23S rRNA gene, which are related to clarithromycin resistance, and Asn87 and Asp91 mutations in gyrA gene, which are related to levofloxacin resistance, were investigated in 102 strains. The resistance rates to clarithromycin, metronidazole, and levofloxacin were 47.3% (53/112), 88.4% (99/112), and 18.8% (21/112), respectively. No resistance to amoxicillin, tetracycline, and furazolidone was observed. Dual and triple resistance percentages were 37.5% (42/112) and 10.7% (12/112), respectively. The detection rate of A2143G mutation in 23S rRNA gene was 83.3% (40/48). The detection rates of mutations of Asn87 and Asp91 in gyrA gene were 52.6% (10/19) and 36.8% (7/19), respectively. Conclusion: The prevalence of H. pylori resistance to clarithromycin, metronidazole, and levofloxacin was high in children in Chongqing, China. The A2143G mutation was detected in most clarithromycin-resistant strains, and Asn87 and Asp91 of gyrA mutation points were common in levofloxacin-resistant strains. In clinical practice, anti-H. pylori therapy should be individualized based on a susceptibility test.  What is Known: • The resistance of H. pylori to antibiotics changes with the geographic areas and that in Asia the resistance rate is high. • Mutation plays a vital role in antibiotics resistance of H. pylori. What is New: • High resistance rates to single and multiple antibiotics in children of Chongqing, a city located in southwest China, were observed. • Molecular assays showed good conformance with susceptibility test results to direct antibiotic resistance of H. pylori.

Indexed as

Helicobacter InfectionsHelicobacter pyloriAnti-Bacterial AgentsChildChinaClarithromycinDrug Resistance, BacterialHumansLevofloxacinMetronidazoleMicrobial Sensitivity TestsRNA, Ribosomal, 23SAnti-Bacterial AgentsClarithromycinLevofloxacinMetronidazoleRNA, Ribosomal, 23SAntibiotic resistanceChildrenHelicobacter pylori (H. pylori)

Identifiers

PMID35469031
OpenAlexW4224884171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.